TY - JOUR
T1 - Mutations in sphingosine-1-phosphate lyase cause nephrosis with ichthyosis and adrenal insufficiency
AU - Lovric, Svjetlana
AU - Goncalves, Sara
AU - Gee, Heon Yung
AU - Oskouian, Babak
AU - Srinivas, Honnappa
AU - Choi, Won Il
AU - Shril, Shirlee
AU - Ashraf, Shazia
AU - Tan, Weizhen
AU - Rao, Jia
AU - Airik, Merlin
AU - Schapiro, David
AU - Braun, Daniela A.
AU - Sadowski, Carolin E.
AU - Widmeier, Eugen
AU - Jobst-Schwan, Tilman
AU - Schmidt, Johanna Magdalena
AU - Girik, Vladimir
AU - Capitani, Guido
AU - Suh, Jung H.
AU - Lachaussée, Noëlle
AU - Arrondel, Christelle
AU - Patat, Julie
AU - Gribouval, Olivier
AU - Furlano, Monica
AU - Boyer, Olivia
AU - Schmitt, Alain
AU - Vuiblet, Vincent
AU - Hashmi, Seema
AU - Wilcken, Rainer
AU - Bernier, Francois P.
AU - Innes, A. Micheil
AU - Parboosingh, Jillian S.
AU - Lamont, Ryan E.
AU - Midgley, Julian P.
AU - Wright, Nicola
AU - Majewski, Jacek
AU - Zenker, Martin
AU - Schaefer, Franz
AU - Kuss, Navina
AU - Greil, Johann
AU - Giese, Thomas
AU - Schwarz, Klaus
AU - Catheline, Vilain
AU - Schanze, Denny
AU - Franke, Ingolf
AU - Sznajer, Yves
AU - Truant, Anne S.
AU - Adams, Brigitte
AU - Désir, Julie
AU - Biemann, Ronald
AU - Pei, York
AU - Ars, Elisabet
AU - Lloberas, Nuria
AU - Madrid, Alvaro
AU - Dharnidharka, Vikas R.
AU - Connolly, Anne M.
AU - Willing, Marcia C.
AU - Cooper, Megan A.
AU - Lifton, Richard P.
AU - Simons, Matias
AU - Riezman, Howard
AU - Antignac, Corinne
AU - Saba, Julie D.
AU - Hildebrandt, Friedhelm
N1 - Funding Information:
Acknowledgments The authors thank the families who contributed to this study. We thank the Yale Center for Mendelian Genomics for WES analysis, U. Pannicke for help in analyzing data, and S. Braun for technical assistance. FH was supported by grants from the NIH (DK076683, DK068306). FH is the Warren E. Grupe Professor. HYG was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education (2015R1D1A1A01056685), by a Nephcure-ASN Foundation Kidney Research Grant, and by a faculty research grant of Yonsei University College of Medicine (6-2015-0175). C Antignac was supported by grants from the Agence Nationale de la Recherche (Gen-Pod project ANR-12-BSV1-0033.01), the European Union's Seventh Framework Programme (FP7/2007-2013/no 305608-EURenOmics), the Fondation Recherche Médicale (DEQ20150331682), and the ''Investments for the Future'' program (ANR-10-IAHU-01). SG was supported by the Program Santé-Science (MD-PhD) of Imagine Institute. FS was supported by the European Union's Seventh Framework Programme (FP7/2007-2013/n 305608-EURenOmics). Immunophenotyping was supported by the German Centre for Infectious Diseases (Thematical Translation Units: Infections of the immunocompromised host). JDS was supported by the John and Edna Beck Chair in Pediatric Cancer Research, the Swim Across America Foundation, and a grant from the NIH (GM66594, NCI CA129438). KS was supported by the Center for Personalized Immunology (supported by the National Health and Medical Research Council of Australia [NHMRC]), the Australian National University, Canberra, Australia. MZ was supported by the German Ministry of Education and Research (Bundesministerium füur Bildung und Forschung, project: GeNeRARe). EW was supported by the Leopoldina Fellowship Program, German National Academy of Sciences Leopoldina (LPDS 2015-07). TJS was supported by grant Jo 1324/1-1 of Deutsche Forschungsgemeinschaft (DFG). MF was supported by grants from the Spanish Society of Nephrology and the Catalan Society of Nephrology. HR was supported by grants from the Swiss National Science Foundation, SystemsX.CH, and the NCCR Chemical Biology. This work was performed under the Care4Rare Canada Consortium funded by Genome Canada, the Canadian Institutes of Health Research, the Ontario Genomics Institute, the Ontario Research Fund, Genome Quebec, and the Children's Hos-pital of Eastern Ontario Research Foundation. We acknowledge the contribution of the high-throughput sequencing platform of the McGill University and Génome Québec Innovation Centre, Montréal, Canada. The names of Care4Rare Canada steering committee members appear in the Supplemental Acknowledgments.
PY - 2017/3/1
Y1 - 2017/3/1
N2 - Steroid-resistant nephrotic syndrome (SRNS) causes 15% of chronic kidney disease cases. A mutation in 1 of over 40 monogenic genes can be detected in approximately 30% of individuals with SRNS whose symptoms manifest before 25 years of age. However, in many patients, the genetic etiology remains unknown. Here, we have performed whole exome sequencing to identify recessive causes of SRNS. In 7 families with SRNS and facultative ichthyosis, adrenal insufficiency, immunodeficiency, and neurological defects, we identified 9 different recessive mutations in SGPL1, which encodes sphingosine-1-phosphate (S1P) lyase. All mutations resulted in reduced or absent SGPL1 protein and/or enzyme activity. Overexpression of cDNA representing SGPL1 mutations resulted in subcellular mislocalization of SGPL1. Furthermore, expression of WT human SGPL1 rescued growth of SGPL1-deficient dpl1? yeast strains, whereas expression of diseaseassociated variants did not. Immunofluorescence revealed SGPL1 expression in mouse podocytes and mesangial cells. Knockdown of Sgpl1 in rat mesangial cells inhibited cell migration, which was partially rescued by VPC23109, an S1P receptor antagonist. In Drosophila, Sply mutants, which lack SGPL1, displayed a phenotype reminiscent of nephrotic syndrome in nephrocytes. WT Sply, but not the disease-associated variants, rescued this phenotype. Together, these results indicate that SGPL1 mutations cause a syndromic form of SRNS.
AB - Steroid-resistant nephrotic syndrome (SRNS) causes 15% of chronic kidney disease cases. A mutation in 1 of over 40 monogenic genes can be detected in approximately 30% of individuals with SRNS whose symptoms manifest before 25 years of age. However, in many patients, the genetic etiology remains unknown. Here, we have performed whole exome sequencing to identify recessive causes of SRNS. In 7 families with SRNS and facultative ichthyosis, adrenal insufficiency, immunodeficiency, and neurological defects, we identified 9 different recessive mutations in SGPL1, which encodes sphingosine-1-phosphate (S1P) lyase. All mutations resulted in reduced or absent SGPL1 protein and/or enzyme activity. Overexpression of cDNA representing SGPL1 mutations resulted in subcellular mislocalization of SGPL1. Furthermore, expression of WT human SGPL1 rescued growth of SGPL1-deficient dpl1? yeast strains, whereas expression of diseaseassociated variants did not. Immunofluorescence revealed SGPL1 expression in mouse podocytes and mesangial cells. Knockdown of Sgpl1 in rat mesangial cells inhibited cell migration, which was partially rescued by VPC23109, an S1P receptor antagonist. In Drosophila, Sply mutants, which lack SGPL1, displayed a phenotype reminiscent of nephrotic syndrome in nephrocytes. WT Sply, but not the disease-associated variants, rescued this phenotype. Together, these results indicate that SGPL1 mutations cause a syndromic form of SRNS.
UR - http://www.scopus.com/inward/record.url?scp=85015884455&partnerID=8YFLogxK
U2 - 10.1172/JCI89626
DO - 10.1172/JCI89626
M3 - Article
C2 - 28165339
AN - SCOPUS:85015884455
SN - 0021-9738
VL - 127
SP - 912
EP - 928
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 3
ER -